Member Info for Oxmil

Same old faces coming out to complain about a new way to talk to management as the ones who complain about lack of transparency. Perhaps this is a way for shareholders to get answers without management spending time doing it

More likely to be another one of viera’s names as he drags his followers in so that he can sell his shares to them and pocket all the cash

I have thought it shows strong regulation if they’ve had to announce the fundraise before the actual placing. Good to see there’s someone putting a decent chunk in too.

Strange to appoint an exec chair rather than new CEO though. Iain Ross has great reputation but he’s already too busy to put enough into this too

Good clear RNS again. Experiment details, results details and tells us what we’re doing next and when. Does anyone know how unique this is to get two sorts of rna in at once? Or how useful?

So you want the company to close? No shareholder is going to vote no when you know there can’t be much left in the bank.

This one was always going to be low because people are still finding out who ME is and what he can do. Anyone who causes a scorched earth effect has to expect it needs to be built from the ground up again from scratch. Wasn’t that the point of the SAG action that they wanted to do that?

Let’s see what ME can do the money when he’s got it

Mostly it’s changes in spread rather than real changes. The bid has come down a bit, but as long as we keep bouncing between 0.5 and 0.7 then it’ll be ready to move on news.

It would be nice to see a few more of those £5k buys today. There’s been a few of them lately.

Good to see another patent filed for Nuvec. Patents are where all the value is in biotech

Only three months Laura, he wasn’t appointed until August. Does that make it even better or more likely that Mark just finished off the deal that someone else started?

Nigel did mention it in the last presentation though didn’t he? I think he was underplaying the importance of it a bit, saying that if it’s not approved it’s because it’s a big market so still good news

According to LinkedIn Nigel is at a big conference this week

Volume is looking up a bit too, it always looks more sustainable when a tick up in share price is on the back of a rise in volume

There’s been a few better sized buys here lately, is this about to get moving?

I’ve just watched the presentation update, I like how Nigel is using investorhub feels like we’re getting decent updates incrementally rather than just waiting for big RNS events

PYC analyse data and build models from data, so they might (or might not) be involved in data analysis on this project, but the biggest point of the story is the sequencing, which is a lab technique. So the sequencing will not be being done by PYC.

Whether or not the data analysis being done for CRUK is related to this project is impossible to tell from this, but I think it’s odd that the PYC announcement was before rather than after (or the same time as) the one from CRUK

I know Christmas is creeping up on us and 2024 is nearly done, but saying it’s ten years since a statement made in 2017 is pushing it a bit

Biotech is slow progress but at least there’s progress

Nice to see the new presentation on the website this morning! Good summary of everything that’s going on

Porky is over on the VAL chat board claiming there’s a class action ongoing about DDDD no evidence that there is though

If that’s a sell at 0.6 then this must be about to move up right? Just need the volumes to creep back up too

Great news flow list - but aren’t we also expecting a new CEO to be announced or did I miss something on that?

If people are looking for biotechs that look unusually more hopeful than normal, I’d look to the smaller ones like N4P as well as here at PYC. Laura, I know you’re on a few others too, but the ones that have been much bigger like SAR are going to struggle a bit longer. I think the small fish will recover quicker in the market as it all starts improving